Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Home Screening for BV to Prevent STDs
NCT00667368Phase 3Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Jul 2008
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of metronidazole in Chlamydia trachomatis infection (CT), gonorrhea, bacterial vaginosis (BV), sponsored by National Institute of Allergy and Infectious Diseases. Started Jul 2008; status: completed.
02
Drugs
metronidazole
03
Conditions
Chlamydia trachomatis infection (CT)gonorrheabacterial vaginosis (BV)
Beyond the preview
Go deeper on NCT00667368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00667368.